A detailed history of Bdf Gestion transactions in Boston Scientific Corp stock. As of the latest transaction made, Bdf Gestion holds 40,582 shares of BSX stock, worth $4.17 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares
40,582
Previous 36,997 9.69%
Holding current value
$4.17 Million
Previous $3.97 Billion 0.3%
% of portfolio
0.47%
Previous 0.44%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 09, 2025

BUY
$97.03 - $108.14 $347,852 - $387,681
3,585 Added 9.69%
40,582 $3.96 Billion
Q2 2025

Jul 11, 2025

SELL
$89.7 - $107.41 $361,670 - $433,077
-4,032 Reduced 9.83%
36,997 $3.97 Billion
Q4 2024

Jan 23, 2025

SELL
$83.62 - $91.5 $445,610 - $487,603
-5,329 Reduced 11.5%
41,029 $3.66 Billion
Q2 2024

Jul 11, 2024

BUY
$67.33 - $77.71 $3.12 Million - $3.6 Million
46,358 New
46,358 $3.57 Billion

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $147B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Bdf Gestion Portfolio

Follow Bdf Gestion and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bdf Gestion, based on Form 13F filings with the SEC.

News

Stay updated on Bdf Gestion with notifications on news.